RMD Q4 2019 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q4 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$705M+13.0% YoY

Gross Profit

$418M59.3% margin

Operating Income

$121M17.2% margin

Net Income

$69M9.8% margin

EPS (Diluted)

$0.48

QoQ Revenue Growth

+6.5%

Cash Flow

Operating Cash Flow

$142M

Free Cash Flow

$118M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$4.1B

Total Liabilities

$2.0B

Stockholders' Equity

$2.1B

Cash & Equivalents

$147M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$705M	$624M	+13.0%
Gross Profit	$418M	$362M	+15.3%
Operating Income	$121M	$147M	-17.6%
Net Income	$69M	$110M	-37.4%

Geographic Segments

Global

$705M60%

Us Canada And Latin America

$471M40%